WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi site has completed GMP release at the end of July, signifying the company's relentless pursuit of excellence in capacity expansion and business growth.
kAmx? ;FDE `g >@?E9D[ (F): )sr 92D C2A:5=J 4@>A=6E65 E96 25G2?465 56D:8?[ 4@?DECF4E:@?[ 6BF:A>6?E BF2=:7:42E:@?[ >65:2 7:== 2?5 v|! C6=62D6 @7 E96 s!b 724:=:EJ H:E9 9:89 677:4:6?4J 2?5 BF2=:EJ] %96 s!b 724:=:EJ :D 6IA64E65 E@ 92G6 2? 2??F2= 42A24:EJ @7 f >:==:@? G:2=D] &A@? E96 s!b @A6C2E:@?2=[ E96 4FCC6?E E@E2= 42A24:EJ @7 E96 6I:DE:?8 E9C66 3:@4@?;F82E6 s! 724:=:E:6D Ws!`[ s!a U2>Aj s!bX C62496D 2AAC@I:>2E6=J `d >:==:@? G:2=D A6C J62C 2E E96 (FI: D:E6]k^Am
kAmsC] kDA2? 4=2DDlQI?\A6CD@?Qmy:>>J {:k^DA2?m[ rt~ @7 (F): )sr[ DE2E65[ Q%96 DF446DD7F= v|! C6=62D6 @7 s!b 724:=:EJ >2C<D ?@E @?=J 2?@E96C >:=6DE@?6 7@C (F): )sr[ 3FE 2=D@ 2 ?6H 368:??:?8 E@H2C5D AFCDF:?8 9:896C 8@2=D] pD 2 <6J A2CE @7 @FC 8=@32= 42A24:EJ 6IA2?D:@?[ H6 2C6 255:?8 @?6 DE2E6\@7\E96\2CE s! 724:=:EJ 6G6CJ J62C[ DJDE6>2E:42==J D42=:?8 @FC 3:@4@?;F82E6 5CF8 AC@5F4E ?6EH@C<] v@:?8 7@CH2C5[ (F): )sr H:== >2:?E2:? 566A :?D:89ED :?E@ :?5FDECJ ?665D[ AC@G:5:?8 8=@32= 4FDE@>6CD H:E9 9:89\BF2=:EJ :?E68C2E65 r#s|~ D6CG:46D] ~FC >:DD:@? C6>2:?D F?H2G6C:?8i E@ 2446=6C2E6 2?5 EC2?D7@C> E96 5:D4@G6CJ[ 56G6=@A>6?E 2?5 >2?F724EFC:?8 @7 3:@4@?;F82E6D E9C@F89 2 4@>AC696?D:G6 @A6?\2446DD A=2E7@C>[ 6?23=:?8 @FC 8=@32= 962=E942C6 A2CE?6CD 2?5 36?67:E:?8 A2E:6?ED H@C=5H:56]Qk^Am
kAms!b 724:=:EJ :D 4@?DECF4E65 :? 244@C52?46 H:E9 E96 9:896DE :?E6C?2E:@?2= DE2?52C5D[ FD6 @7 36DE 6BF:A>6?E 2?5 :?4@CA@C2E6D :?5FDECJ\=625:?8 E649?@=@8:6D] kDEC@?8mxE 762EFC6D 2 5:DE:?4E:G6 724:=:EJ 56D:8?[ C:8@C@FD C:D< 4=2DD:7:42E:@? >2?286>6?E[ 25G2?465 9:89\A@E6?4J 2?5 DE6C:=6 6BF:A>6?E[ :??@G2E:G6 D:?8=6\FD6 E649?@=@8J[ 2?5 2 4@>AC696?D:G6 6?G:C@?>6?E2= >@?:E@C:?8 DJDE6>k^DEC@?8m] s!b 724:=:EJ AC@G:56D >2?F724EFC:?8 D6CG:46 7@C =:BF:5 2?5 =J@A9:=:K65 DE6C:=6 AC@5F4ED[ @776C:?8 4FDE@>6CD @?6\DE@A D@=FE:@?D 7C@> 4=:?:42= E@ 4@>>6C4:2= >2?F724EFC:?8]k^Am
kAms!b 724:=:EJ >66ED E96 9:896DE :?E6C?2E:@?2= BF2=:EJ DE2?52C5D 2?5 7F==J 4@>A=:6D H:E9 v|! C68F=2E:@?D 7C@> E96 usp[ t|p[ 2?5 }|!p[ 6?DFC:?8 AC@46DD 4@>A=:2?46 2?5 AC@5F4E BF2=:EJ] s!b 724:=:EJ :?E68C2E6D >2E6C:2= 5:D:?764E:@?[ 4=62?:?8 2?5 DE6C:=:K2E:@?[ 7@C>F=2E:@?[ 7:==:?8[ =J@A9:=:K2E:@?[ 42AA:?8[ 6IE6C?2= H2D9:?8[ G:DF2= :?DA64E:@? 2?5 A24<28:?8] %96 u:==:?8 AC@46DD 762EFC6D 2FE@>2E:4 6>AEJ:?8 s$ 7C@> 328[ `__T @?=:?6 H6:89E 4964<[ ?@?\G24FF> DE@AA6C:?8 2?5 9:89\DA665 7:==:?8 FA E@ b__ G:2=D A6C >:?FE6] p 5F2=\42>6C2 DJDE6> 56E64ED E96 DE@AA6C 96:89E 2?5 C6;64ED AC@5F4ED H:E9 >:DD:?8 @C 9:89 DE@AA6C AC@5F4ED @?=:?6] %96 C@3@E:4 EC2J A24<28:?8 2?5 2FE@>2E65 A24<28:?8 =:?6 AC@G:56D =236=:?8[ 42CE@? A24<28:?8[ 6?5 @7 =:?6 A24<28:?8[ 2?5 EC24623:=:EJ[ 6?23=:?8Â 677:4:6?E 2?5 AC64:D6 >2?F724EFC:?8]k^Am
kAmkDEC@?8mp3@FE (F): )srk^Am
kAmk^DEC@?8m(F): )sr r2J>2? x?4] WDE@4< 4@56i aaeg]wzX :D 2 8=@32==J C64@8?:K65 4@?EC24E C6D62C49[ 56G6=@A>6?E[ 2?5 >2?F724EFC:?8 @C82?:K2E:@? Wr#s|~X DA64:2=:K:?8 :? 3:@4@?;F82E6D] %96 4@>A2?J @776CD 2 H:56 C2?86 @7 :??@G2E:G6 4@?;F82E:@? 2?5 A2J=@25\=:?<6C E649?@=@8:6D E@ 724:=:E2E6 E96 56G6=@A>6?E @7 ?6IE\86?6C2E:@? 2?E:3@5J\5CF8 4@?;F82E6D WpsrDX] u@4FD65 @? 62C=J\DE286 C6D62C49 2?5 56G6=@A>6?E @7 psrD 2?5 @E96C 3:@4@?;F82E6D[ (F): )sr @776CD 4@>AC696?D:G6 @?6\DE@A D6CG:46D 7C@> 4=:?:42= E@ 4@>>6C4:2= >2?F724EFC:?8] xED D6CG:46D 4@G6C 2?E:3@5J :?E6C>65:2E6D 2?5 @E96C 3:@=@8:4D :?E6C>65:2E6D[ 496>:42= A2J=@25D 2?5 =:?<6CD[ 2D H6== 2D 3:@4@?;F82E6 5CF8 DF3DE2?46D 2?5 5CF8 AC@5F4ED] u@C >@C6 :?7@C>2E:@? 23@FE (F): )sr[ A=62D6 G:D:Ei k2 9C67lQ9EEAi^^HHH]HFI:I54]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]HFI:I54]4@>k^2mk^Am
kAmkDEC@?8m(F): )sr r@?E24EDk^Am
kAmk^DEC@?8mx?G6DE@Ci k2 9C67lQ>2:=E@iHFI:I54]:CoHFI:3:@=@8:4D]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHFI:I54]:CoHFI:3:@=@8:4D]4@>k^2mk^Am
kAm|65:2i k2 9C67lQ>2:=E@iHFI:I540ACoHFI:3:@=@8:4D]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHFI:I540ACoHFI:3:@=@8:4D]4@>k^2mk^Am
kAmqsi k2 9C67lQ>2:=E@iHFI:I540:?7@oHFI:3:@=@8:4D]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHFI:I540:?7@oHFI:3:@=@8:4D]4@>k^2m k^Am
kAm k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^4a`a]?6E^4^:>8^72G:4@?]A?8nD?lr}ccba_U2>AjD5la_ad\_g\_cQ ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^HFI:\I54\249:6G6D\8>A\C6=62D6\@7\?6H=J\=2F?4965\5Ab\724:=:EJ\2E\HFI:\D:E6\D42=:?8\7FCE96C\5CF8\AC@5F4E\>2?F724EFC:?8\42A24:EJ\b_ada`bf_]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^HFI:\I54\249:6G6D\8>A\C6=62D6\@7\?6H=J\=2F?4965\5Ab\724:=:EJ\2E\HFI:\D:E6\D42=:?8\7FCE96C\5CF8\AC@5F4E\>2?F724EFC:?8\42A24:EJ\b_ada`bf_]9E>=k^2mk^Am
kAm$~&#rt (F): )srk^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}ccba_U2>Aj%C2?D>:DD:@?0x5la_ad_g_caa`b!#0}t($0&$!#00000r}ccba_U2>Ajs2E6x5la_ad_g_cQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us.